Keywords: Stroke, Stroke, GABA, Glx
Motivation: Neurotransmitters are involved in diseases associated with cognitive impairment.
Goal(s): Investigate the changes of the main inhibitory (gamma-aminobutyric acid, GABA) and excitatory neurotransmitters (glutamate and glutamine, Glx) for stroke patients and their correlation with cognitive impairment.
Approach: GABA and Glx were measured using Meshcher-Garwood point-resolved spectroscopy (MEGA-PRESS) sequence in 20 ischemic stroke patients.
Results: GABA to total creatine ratio (GABA/Cr) were reduced in the ipsilateral thalamus compared to the contralateral thalamus, and reduced GABA/Cr in ipsilateral thalamus was strong correlated with cognitive impairment. Thalamic GABA level could serve as a potential target for the evaluation and treatment of patients with post-stroke cognitive impairment.
Impact: The levels of GABA, glutamate and glutamine (Glx) in thalamus can be noninvasively quantified using MRS based on MEGA-PRESS technique in ischemic stroke patients. Reduced GABA level in ipsilateral thalamus was associated with cognitive impairment in ischemic patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords